CVE-2022-21543

Description

Vulnerability in the PeopleSoft Enterprise PeopleTools product of Oracle PeopleSoft (component: Updates Environment Mgmt). Supported versions that are affected are 8.58 and 8.59. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise PeopleSoft Enterprise PeopleTools. Successful attacks of this vulnerability can result in takeover of PeopleSoft Enterprise PeopleTools. CVSS 3.1 Base Score 9.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H).

9.8

CVSS

Severity: Critical

CVSS 3.1 •

EPSS 1.43% Top 25%

Vendor Advisory oracle.com

Affected: Oracle Corporation PeopleSoft Enterprise PT PeopleTools

References

Link	Tags
https://www.oracle.com/security-alerts/cpujul2022.html	patch vendor advisory

Frequently Asked Questions

What is the severity of CVE-2022-21543?: CVE-2022-21543 has been scored as a critical severity vulnerability.
How to fix CVE-2022-21543?: To fix CVE-2022-21543, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-21543 being actively exploited in the wild?: It is possible that CVE-2022-21543 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-21543?: CVE-2022-21543 affects Oracle Corporation PeopleSoft Enterprise PT PeopleTools.

This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.